Music |
Video |
Movies |
Chart |
Show |
Ongoing Clinical Trials in Rare GU Malignancies (GU Oncology Now) View | |
Clinical Trials for Rare Bladder Cancers (Bladder Cancer Advocacy Network) View | |
Highlighting Clinical Trials: Non-Muscle Invasive Bladder Cancer | Current Trials (Bladder Cancer Advocacy Network) View | |
Explaining Clinical Trials for Bladder Cancer (Bladder Cancer Advocacy Network) View | |
Advances in Treating Upper Tract Urothelial Cancer (Grand Rounds in Urology) View | |
EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab (OncBrothers: Practice-Changing Cancer Discussions) View | |
Genitourinary cancer trials at ANZUP 2023: SUBDUE-1 and ZiPUP (VJOncology) View | |
Molecular Biomarkers and Risk Stratification in High-Risk Non-Muscle Invasive Bladder Cancer (GU Oncology Now) View | |
KEYNOTE-B61 Study Results and a Focus on Non-Clear Cell Kidney Cancer (GU Oncology Now) View | |
Dr. Martin Voss on the Latest Research Updates in Treatments, Biomarkers, and More for RCC (GU Oncology Now) View |